-
1
-
-
84976479130
-
Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes
-
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84.
-
(2016)
Hepatology
, vol.64
, pp. 73-84
-
-
Younossi, Z.M.1
Koenig, A.B.2
Abdelatif, D.3
Fazel, Y.4
Henry, L.5
Wymer, M.6
-
2
-
-
0033038672
-
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity
-
Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1493.
-
(1999)
Gastroenterology
, vol.116
, pp. 1413-1493
-
-
Matteoni, C.A.1
Younossi, Z.M.2
Gramlich, T.3
Boparai, N.4
Liu, Y.C.5
McCullough, A.J.6
-
3
-
-
84885304313
-
Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD)
-
Stepanova M, Rafiq N, Makhlouf H, Agrawal R, Kaur I, Younoszai Z, et al. Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci 2013;58:3017-3023.
-
(2013)
Dig Dis Sci
, vol.58
, pp. 3017-3023
-
-
Stepanova, M.1
Rafiq, N.2
Makhlouf, H.3
Agrawal, R.4
Kaur, I.5
Younoszai, Z.6
-
4
-
-
84861543083
-
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
-
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005-2023.
-
(2012)
Hepatology.
, vol.55
, pp. 2005-2023
-
-
Chalasani, N.1
Younossi, Z.2
Lavine, J.E.3
Diehl, A.M.4
Brunt, E.M.5
Cusi, K.6
-
5
-
-
58849134985
-
Long-term follow-up of patients with nonalcoholic fatty liver
-
Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009;7:234-238.
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, pp. 234-238
-
-
Rafiq, N.1
Bai, C.2
Fang, Y.3
Srishord, M.4
McCullough, A.5
Gramlich, T.6
-
6
-
-
84928209634
-
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
-
Ekstedt M, Hagström H, Nasr P, Fredrikson M, Stål P, Kechagias S, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 2015;61:1547-1554.
-
(2015)
Hepatology
, vol.61
, pp. 1547-1554
-
-
Ekstedt, M.1
Hagström, H.2
Nasr, P.3
Fredrikson, M.4
Stål, P.5
Kechagias, S.6
-
7
-
-
11144351102
-
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
-
Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42:132-138.
-
(2005)
J Hepatol
, vol.42
, pp. 132-138
-
-
Adams, L.A.1
Sanderson, S.2
Lindor, K.D.3
Angulo, P.4
-
8
-
-
4644297019
-
Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies
-
Fassio E, Alvarez E, Domínguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 2004;40:820-826.
-
(2004)
Hepatology
, vol.40
, pp. 820-826
-
-
Fassio, E.1
Alvarez, E.2
Domínguez, N.3
Landeira, G.4
Longo, C.5
-
9
-
-
77953971188
-
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
-
Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010;59:969-974.
-
(2010)
Gut
, vol.59
, pp. 969-974
-
-
Wong, V.W.1
Wong, G.L.2
Choi, P.C.3
Chan, A.W.4
Li, M.K.5
Chan, H.Y.6
-
10
-
-
84927796763
-
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management
-
McPherson S, Hardy T, Henderson E, Burt A, Day CP, Anstee QM. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol 2015;62:1148-1155.
-
(2015)
J Hepatol
, vol.62
, pp. 1148-1155
-
-
McPherson, S.1
Hardy, T.2
Henderson, E.3
Burt, A.4
Day, C.P.5
Anstee, Q.M.6
-
11
-
-
0019152816
-
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
-
Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-438.
-
(1980)
Mayo Clin Proc
, vol.55
, pp. 434-438
-
-
Ludwig, J.1
Viggiano, T.R.2
McGill, D.B.3
Oh, B.J.4
-
12
-
-
84945539188
-
Liver histology and clinical trials for nonalcoholic steatohepatitis-perspectives from 2 pathologists
-
Kleiner DE, Bedossa P. Liver histology and clinical trials for nonalcoholic steatohepatitis-perspectives from 2 pathologists. Gastroenterology 2015;149:1305-1308.
-
(2015)
Gastroenterology
, vol.149
, pp. 1305-1308
-
-
Kleiner, D.E.1
Bedossa, P.2
-
13
-
-
84923893879
-
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States
-
Wong R, Aguilar M, Cheung R, Perumpail R, Harrison S, Younossi ZM, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015;148:547-555.
-
(2015)
Gastroenterology
, vol.148
, pp. 547-555
-
-
Wong, R.1
Aguilar, M.2
Cheung, R.3
Perumpail, R.4
Harrison, S.5
Younossi, Z.M.6
-
14
-
-
84955213803
-
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
-
Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, Mishra A, Erario M, et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology 2015;62:1723-1730.
-
(2015)
Hepatology
, vol.62
, pp. 1723-1730
-
-
Younossi, Z.M.1
Otgonsuren, M.2
Henry, L.3
Venkatesan, C.4
Mishra, A.5
Erario, M.6
-
15
-
-
84905842828
-
The portrait of an adult liver transplant recipient in the United States from 1987 to 2013
-
Stepanova M, Wai H, Saab S, Mishra A, Venkatesan C, Younossi ZM. The portrait of an adult liver transplant recipient in the United States from 1987 to 2013. JAMA Intern Med 2014;174:1407-1409.
-
(2014)
JAMA Intern Med
, vol.174
, pp. 1407-1409
-
-
Stepanova, M.1
Wai, H.2
Saab, S.3
Mishra, A.4
Venkatesan, C.5
Younossi, Z.M.6
-
16
-
-
85038942437
-
Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease
-
Sayiner M, Stepanova M, Pham H, Noor B, Walters M, Younossi ZM. Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease. BMJ Open Gastroenterol 2016;3:e000106.
-
(2016)
BMJ Open Gastroenterol
, vol.3
-
-
Sayiner, M.1
Stepanova, M.2
Pham, H.3
Noor, B.4
Walters, M.5
Younossi, Z.M.6
-
17
-
-
84992445161
-
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
-
Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology 2016;64:1577-1586.
-
(2016)
Hepatology
, vol.64
, pp. 1577-1586
-
-
Younossi, Z.M.1
Blissett, D.2
Blissett, R.3
Henry, L.4
Stepanova, M.5
Younossi, Y.6
-
18
-
-
79957521377
-
Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality
-
Younossi ZM, Stepanova M, Rafiq N, Makhlouf H, Younoszai Z, Agrawal R, et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology 2011;53:1874-1882.
-
(2011)
Hepatology
, vol.53
, pp. 1874-1882
-
-
Younossi, Z.M.1
Stepanova, M.2
Rafiq, N.3
Makhlouf, H.4
Younoszai, Z.5
Agrawal, R.6
-
19
-
-
84938057875
-
Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease
-
e10.
-
Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2015;149:389-397.e10.
-
(2015)
Gastroenterology
, vol.149
, pp. 389-397
-
-
Angulo, P.1
Kleiner, D.E.2
Dam-Larsen, S.3
Adams, L.A.4
Bjornsson, E.S.5
Charatcharoenwitthaya, P.6
-
20
-
-
0031844760
-
Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations
-
Younossi ZM, Gramlich T, Liu YC, Matteoni C, Petrelli M, Goldblum J, et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol 1998;11:560-565.
-
(1998)
Mod Pathol
, vol.11
, pp. 560-565
-
-
Younossi, Z.M.1
Gramlich, T.2
Liu, Y.C.3
Matteoni, C.4
Petrelli, M.5
Goldblum, J.6
-
21
-
-
20044374023
-
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
-
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321.
-
(2005)
Hepatology
, vol.41
, pp. 1313-1321
-
-
Kleiner, D.E.1
Brunt, E.M.2
Van Natta, M.3
Behling, C.4
Contos, M.J.5
Cummings, O.W.6
-
22
-
-
84938150863
-
The hierarchical model of NAFLD: prognostic significance of histologic features in NASH
-
Loomba R, Chalasani N. The hierarchical model of NAFLD: prognostic significance of histologic features in NASH. Gastroenterology 2015;149:278-281.
-
(2015)
Gastroenterology
, vol.149
, pp. 278-281
-
-
Loomba, R.1
Chalasani, N.2
-
23
-
-
1242296971
-
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease
-
Gramlich T, Kleiner DE, McCullough AJ, Matteoni CA, Boparai N, Younossi ZM. Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. Hum Pathol 2004;35:196-199.
-
(2004)
Hum Pathol
, vol.35
, pp. 196-199
-
-
Gramlich, T.1
Kleiner, D.E.2
McCullough, A.J.3
Matteoni, C.A.4
Boparai, N.5
Younossi, Z.M.6
-
24
-
-
84995550141
-
Thiazolidinediones for nonalcoholic steatohepatitis: a meta-analysis of randomized clinical trials
-
He L, Liu X, Wang L, Yang Z. Thiazolidinediones for nonalcoholic steatohepatitis: a meta-analysis of randomized clinical trials. Medicine (Baltimore). 2016;95:e4947.
-
(2016)
Medicine (Baltimore).
, vol.95
-
-
He, L.1
Liu, X.2
Wang, L.3
Yang, Z.4
-
25
-
-
84995360076
-
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice
-
Dulai PS, Sirlin CB, Loomba R. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice. J Hepatol 2016;65:1006-1016.
-
(2016)
J Hepatol
, vol.65
, pp. 1006-1016
-
-
Dulai, P.S.1
Sirlin, C.B.2
Loomba, R.3
-
26
-
-
84997765916
-
The therapeutic landscape of non-alcoholic steatohepatitis
-
Perazzo H, Dufour JF. The therapeutic landscape of non-alcoholic steatohepatitis. Liver Int. 2017;37:634-647.
-
(2017)
Liver Int.
, vol.37
, pp. 634-647
-
-
Perazzo, H.1
Dufour, J.F.2
-
27
-
-
84975156689
-
Nonalcoholic steatohepatitis is associated with increased mortality in obese patients undergoing bariatric surgery
-
Goossens N, Hoshida Y, Song WM, Jung M, Morel P, Nakagawa S, et al. Nonalcoholic steatohepatitis is associated with increased mortality in obese patients undergoing bariatric surgery. Clin Gastroenterol Hepatol 2016;14:1619-1628.
-
(2016)
Clin Gastroenterol Hepatol
, vol.14
, pp. 1619-1628
-
-
Goossens, N.1
Hoshida, Y.2
Song, W.M.3
Jung, M.4
Morel, P.5
Nakagawa, S.6
-
28
-
-
84986222780
-
SAF score and mortality in NAFLD after up to 41 years of follow-up
-
Hagström H, Nasr P, Ekstedt M, Kechagias S, Stål P, Bedossa P, et al. SAF score and mortality in NAFLD after up to 41 years of follow-up. Scand J Gastroenterol 2017;52:87-91.
-
(2017)
Scand J Gastroenterol
, vol.52
, pp. 87-91
-
-
Hagström, H.1
Nasr, P.2
Ekstedt, M.3
Kechagias, S.4
Stål, P.5
Bedossa, P.6
-
29
-
-
84868008620
-
Noninvasive diagnosis of NASH and liver fibrosis within the spectrum of NAFLD
-
Alkhouri N, McCullough AJ. Noninvasive diagnosis of NASH and liver fibrosis within the spectrum of NAFLD. Gastroenterol Hepatol (N Y) 2012;8:661-668.
-
(2012)
Gastroenterol Hepatol (N Y)
, vol.8
, pp. 661-668
-
-
Alkhouri, N.1
McCullough, A.J.2
-
30
-
-
75449102165
-
Long-Term Mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?
-
Erratum in Hepatology 2010;511868.
-
Angulo P. Long-Term Mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 2010;51:373-375. Erratum in: Hepatology 2010;51:1868.
-
(2010)
Hepatology
, vol.51
, pp. 373-375
-
-
Angulo, P.1
-
31
-
-
84859590655
-
Clinical evidence for the regression of liver fibrosis
-
Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. J Hepatol 2012;56:1171-1180.
-
(2012)
J Hepatol
, vol.56
, pp. 1171-1180
-
-
Ellis, E.L.1
Mann, D.A.2
-
32
-
-
84939195004
-
Prognostic value of non-invasive fibrosis and steatosis tools, hepatic venous pressure gradient (HVPG) and histology in nonalcoholic steatohepatitis
-
Sebastiani G, Alshaalan R, Wong P, Rubino M, Salman A, Metrakos P, et al. Prognostic value of non-invasive fibrosis and steatosis tools, hepatic venous pressure gradient (HVPG) and histology in nonalcoholic steatohepatitis. PLoS One 2015;10:e0128774.
-
(2015)
PLoS One
, vol.10
-
-
Sebastiani, G.1
Alshaalan, R.2
Wong, P.3
Rubino, M.4
Salman, A.5
Metrakos, P.6
-
33
-
-
84994589859
-
Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients
-
Leung JC, Loong TC, Wei JL, Wong GL, Chan AW, Choi PC, et al. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. Hepatology 2017;65:54-64.
-
(2017)
Hepatology
, vol.65
, pp. 54-64
-
-
Leung, J.C.1
Loong, T.C.2
Wei, J.L.3
Wong, G.L.4
Chan, A.W.5
Choi, P.C.6
-
34
-
-
79959573040
-
Endpoints and clinical trial design for nonalcoholic steatohepatitis
-
Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 2011;54:344-353.
-
(2011)
Hepatology
, vol.54
, pp. 344-353
-
-
Sanyal, A.J.1
Brunt, E.M.2
Kleiner, D.E.3
Kowdley, K.V.4
Chalasani, N.5
Lavine, J.E.6
|